Month: September 2021

Endexx Provides Shareholder Update on Previously Disclosed Corporate Actions Cave Creek, AZ, Sept. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Endexx® Corporation (OTC: EDXC), a leading producer and manufacturer of hemp-derived CBD wellness products since 2014, presented a corporate update at invitation to an Endexx Shareholder Ambassador group on Facebook. Endexx was testing its new shareholder communication platform being utilized to host live events and company updates with a goal of engaging with its shareholders on a more frequent and personal basis.  “Embracing technology and integrating new tools to better communicate with our stakeholders who are seeking to engage more with their investment has been a major initiative over the last fiscal year,” stated Todd Davis, CEO of Endexx.  Davis added, “In Endexx’s new...

VANCOUVER, British Columbia, Sept. 15, 2021 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis” or the “Company”) announces that the Company received an interim order issued by the Supreme Court of British Columbia (“BCSC”) pursuant to the British Columbia Business Corporations Act (the “BCBCA”) providing for the calling and holding of the meeting of the registered holders of the $23,000,000 principal amount of 5.3% promissory notes due January 25, 2023 (the “Notes”) being held virtually on Monday, September 27, 2021 at 8:00 a.m. (the “Noteholders’ Meeting”) and other procedural matters. Caravel CAD Fund Ltd. (“Caravel”) opposed the grant of the Interim Order, and in particular, the date proposed to be set for the Noteholders’ Meeting. However, on the application for the Interim Order, the Court rejected...

RESEARCH TRIANGLE PARK, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) has recommended ORLADEYO® (berotralstat) for preventing recurrent attacks of hereditary angioedema (HAE) in eligible patients 12 years and older if they have at least two attacks per month. With this recommendation, HAE patients in England, Wales and Northern Ireland will have access to the first oral, once-daily therapy for routine prevention of recurrent HAE attacks. “HAE is a very rare genetic condition which is at best painful and debilitating, and can be fatal if left untreated. The unpredictability of the condition severely affects quality of life for patients and their families,” said Laura Szutowicz, chief executive...

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, Sept. 15, 2021 (GLOBE NEWSWIRE) — Questerre Energy Corporation (“Questerre” or the “Company”) (TSX,OSE:QEC) reported today it has recently completed the engineering and work program to test a carbon storage reservoir in Quebec. The operation includes an injectivity test to estimate the optimal injection rate for carbon dioxide into the storage reservoir. The test will also estimate the volume that can be safely stored in this reservoir situated at a depth of over 1000m below the surface in the Potsdam, a Cambrian age sandstone formation. The Company is finalizing its application to the Government and plans to execute this program once the application is approved...

TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA: 20MP) announces an immediate voluntary retraction of the data contained in its news release dated December 10, 2020 with respect to its Ivectosol™ pre-clinical canine trial data, which was also referenced in a subsequent news release dated January 14, 2021. The Company has discovered errors in the results disclosed in the December 10, 2020 and January 14, 2021 news releases that were based on an erroneous analysis as well as the incorrect use of comparator data that should not have been applied to the pharmacokinetic analysis. The Company has immediately implemented corrective internal processes and has initiated steps to re-run the trial and will provide an update regarding the Ivectosol™ data package with the...

CALGARY, Alberta, Sept. 15, 2021 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced that its previously announced cash tender offer (the “Any and All Tender Offer”) for any and all of its outstanding 3.950% Notes due 2022 (the “3.950% Notes”) and 3.000% Notes due 2022 (the “3.000% Notes” and, together with the 3.950% Notes, the “Any and All Notes”) (CUSIP Nos. 448055AJ2 and 15135UAG4, respectively) expired at 5:00 p.m., New York City time, on September 15, 2021. According to information provided by D.F. King & Co., Inc., the tender and information agent for the Any and All Tender Offer, $252,644,000 aggregate principal amount of the 3.950% Notes and $294,017,000 aggregate principal amount of the 3.000% Notes were validly tendered and not validly withdrawn prior to or at the expiration of the Any...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTIONOR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. VANCOUVER, British Columbia, Sept. 15, 2021 (GLOBE NEWSWIRE) — P2 Gold Inc. (“P2” or the “Company”) (TSX-V:PGLD) reports that it intends to complete a non-brokered private placement (the “Private Placement”) consisting of up to 1,000,000 flow-through common shares in the capital of the Company (the “Common Shares”) that qualify as flow-through shares for purposes of the Income Tax Act (Canada), at a price of $0.50 per Common Share for gross proceeds of up to $500,000. The gross proceeds of the Private Placement will be used to fund exploration expenditures on the BAM Property and for other Canadian Exploration Expenses that will qualify as “flow through...

Boca Raton, FL, Sept. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Grom Social Enterprises, Inc. (NASDAQ:GROM) (“Grom” or the “Company”), the emerging social media and family entertainment company, today announced the closing of a $4.4 million private placement. The Investment is in the form of a 10% Original Issue Discount convertible note in the principal amount of $4,400,000 that has an 18-month maturity and a fixed conversion price of $4.20 per share of common stock, subject to adjustment, and warrants to purchase 813,278 shares of common stock with an exercise price of $4.20 per share, subject to adjustment. GROM is required to make monthly payments in either cash or shares, commencing 75 days after closing. GROM has agreed to file a registration statement registering for resale the shares of...